AAIC 2025 Abstract
Combination of focused ultrasound blood‐brain barrier opening with Lecanemab therapy in mild Alzheimer's disease
Trial in peopleInterventions
Abstract
Background: Alzheimer's disease (AD) is a major neurodegenerative disorder affecting millions worldwide, with limited treatment options and significant challenges in drug delivery.
